1.
A new paradigm of cardiohematological monitoring in patients with chronic myeloid leukemia taking tyrosine kinase inhibitors. UJC [Internet]. 2022 Jul. 5 [cited 2024 Jul. 19];29(1-2):72-86. Available from: https://ucardioj.com.ua/index.php/UJC/article/view/300